Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

K B Bukan, A Nardo-Marino, C Hagdrup, M Boennelycke, M F Breinholdt, C Schöllkopf, H V Nielsen, D El Fassi

Original languageEnglish
JournalScandinavian Journal of Rheumatology
Issue number4
Pages (from-to)342-343
Number of pages2
Publication statusPublished - 2019


  • Aged
  • Antirheumatic Agents/administration & dosage
  • Bone Marrow Examination/methods
  • Dexamethasone/administration & dosage
  • Fatal Outcome
  • Humans
  • Immunoglobulins, Intravenous/administration & dosage
  • Infliximab/administration & dosage
  • Leishmaniasis, Visceral/diagnosis
  • Lymphohistiocytosis, Hemophagocytic/diagnosis
  • Male
  • Patient Care Management/methods
  • Sarcoidosis/drug therapy
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors

Cite this